Pulse Biosciences, Inc.
General ticker "PLSE" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.1B (TTM average)
Pulse Biosciences, Inc. follows the US Stock Market performance with the rate: 6.1%.
Estimated limits based on current volatility of 2.0%: low 13.18$, high 13.72$
Factors to consider:
- Total employees count: 56 (-8.2%) as of 2023
- North America accounted for 0.0% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Operational and conduct risks, Economic downturns and volatility, FDA actions/partner dependency, Key management loss, Technological obsolescence
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [9.41$, 20.93$]
- 2025-12-31 to 2026-12-31 estimated range: [6.59$, 15.49$]
Financial Metrics affecting the PLSE estimates:
- Negative: with PPE of -26.8 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -3.48 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.01 > -0.66
- Positive: Shareholder equity ratio, % of 86.71 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
Short-term PLSE quotes
Long-term PLSE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.70MM | $0.00MM | $0.00MM |
| Operating Expenses | $58.76MM | $43.57MM | $56.26MM |
| Operating Income | $-58.06MM | $-43.57MM | $-56.26MM |
| Non-Operating Income | $-0.45MM | $1.36MM | $2.67MM |
| R&D Expense | $20.84MM | $27.80MM | $32.34MM |
| Income(Loss) | $-58.51MM | $-42.21MM | $-53.59MM |
| Profit(Loss)* | $-58.51MM | $-42.21MM | $-53.59MM |
| Stockholders Equity | $-2.25MM | $44.36MM | $114.86MM |
| Assets | $77.88MM | $59.15MM | $132.46MM |
| Operating Cash Flow | $-47.01MM | $-33.04MM | $-36.34MM |
| Capital expenditure | $0.40MM | $0.12MM | $0.12MM |
| Investing Cash Flow | $-0.40MM | $-0.12MM | $-0.12MM |
| Financing Cash Flow | $79.94MM | $16.39MM | $110.14MM |
| Earnings Per Share** | $-1.72 | $-0.88 | $-0.92 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.